![]() |
Dr. Quinn's investigations have involved the study of the epidemiologic, virologic and immunologic features of HIV infection in Africa, the Caribbean, South America and Asia. In 1983, he led the first group of scientists to Haiti and central Africa to determine the extent of HIV within those countries. In 1984, he helped establish the interagency project called "Projet SIDA" in Kinshasa, Zaire, which was the largest AIDS investigative project in sub-Saharan Africa. Since then he has generated numerous global initiatives and research programs in 28 countries. He was among the first to describe the heterosexual transmission of HIV in Haiti, Zaire, Kenya, India, and more recently, China. He demonstrated that HIV viral load was the single most important predictor of HIV perinatal and sexual transmission, correlating this with timing of infection and natural history. More recent collaborative studies in Uganda have also provided evidence that male circumcision can reduce HIV acquisition by at least 50%.
Dr. Quinn is a member of the Institute of Medicine of the National Academy of Science. He is a fellow of the Infectious Disease Society of America, a member of the American Association of Physicians, and a member of the American Society for Clinical Investigation. He is an advisor/consultant on HIV and STDs to the WHO, PAHO, UNAIDS and FDA. He served on the Board of Directors for the Infectious Diseases Society of America and the National Foundation for Infectious Diseases. He is a founding member of the Academic Alliance for AIDS Care and Prevention in Africa and helped design the Infectious Diseases Institute of Makerere University School of Medicine where he also holds an adjunct appointment in medicine. He is the recipient of multiple awards and honors and is an author of more than 700 publications on HIV, STDs and infectious diseases.
Disclosures
Dr. Quinn reports that he has no significant relationships to disclose.